Tentative pending approval from Dr Braunwald
SECTION I: EPIDEMIOLOGY
1. General Population and Global Cardiovascular Risk Prediction
2. Hypertension in Latin/Hispanic Population
3. Hypertension in East Asians and Native Hawaiians
4. Hypertension in South Asians
5. Hypertension in Women - NEW
SECTION II: PATHOPHYSIOLOGY
6. Pathogenesis of Hypertension
7. Genetics of Hypertension
8. Inflammation and Immunity in Hypertension
SECTION III: DIAGNOSIS AND EVALUATION
9. Environmental Factors Affecting Blood Pressure Development
10. Office Blood Pressure Measurement
11. Home Monitoring of Blood Pressure
12. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management
13. White Coat and Masked Hypertension
14. Secondary Hypertension: Renovascular Hypertension
15. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States
16. Secondary Hypertension: Pheochromocytoma
17. Secondary Hypertension: Sleep Disturbances including Sleep Apnea
18. Hypertension in Children: Diagnosis and Treatment
SECTION IV: RISK STRATIFICATION
19. Natural History of Untreated Hypertension
20. Isolated Systolic Hypertension
21. Assessment of Target Organ Damage
SECTION V: ANTIHYPERTENSIVE THERAPY
22. Diet and Blood Pressure
23. Diuretic Therapy
24. Peripheral Adrenergic Blockers
25. Renin Angiotensin Aldosterone System Blockers
26. Calcium Channel Blockers
27. Central Sympathetic Agents and Direct Vasodilators
28. Mineralocorticoid Receptor Antagonists – NEW
29. Use of Combination Therapies
30. Devices Therapies
31. Alternative/Complementary Medicine
SECTION VI: HYPERTENSION MANAGEMENT
32. Approach to Uncomplicated Primary Hypertension
33. Ischemic Heart Disease
34. Heart Failure
35. Kidney Disease including Dialysis
36. Transplant Hypertension
37. Obesity
38. Cerebrovascular Disease
39. Diabetes Mellitus
40. Dyslipidemia
SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS
41. Hypertension in Pregnancy
42. Hypertension in Older People
43. Hypertension in African Americans
44. Baroreceptor Dysfunction/Orthostatic Hypotension
45. Resistant Hypertension
46. Hypertension and the Perioperative Period
47. Aorta and Peripheral Arterial Disease in Hypertension
48. Hypertensive Emergencies
49. Exercise and Hypertension - NEW
SECTION VIII: OUTCOME TRIALS
50. Meta-Analyses of Hypertension Trials: The Blood Pressure Lowering Treatment Trialists’ Collaboration
SECTION IX: HYPERTENSION TREATMENT IN THE FUTURE
51. Team-Based Care for Hypertension Management
52. Understanding and Improving Medication Adherence
53. Telemedicine and Digital Health for Hypertension Management - NEW
